• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液凝固因子IX:结构、功能与调节

Blood Coagulation Factor IX: Structure, Function, and Regulation.

作者信息

Ivanciu Lacramioara, Camire Rodney M

机构信息

Division of Hematology and the Raymond G. Perelman Center for Cellular and Molecular Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

出版信息

IUBMB Life. 2025 May;77(5):e70024. doi: 10.1002/iub.70024.

DOI:10.1002/iub.70024
PMID:40402203
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12097292/
Abstract

Blood coagulation factor IX plays a crucial role in the intrinsic pathway of coagulation by generating factor Xa, ultimately leading to thrombin formation. Over the past 50 years, extensive research has deepened our understanding of the biology, physiology, pathology, biochemistry, and molecular genetics of factor IX. This wealth of knowledge has revealed how the factor IX gene and protein evolved, how factor IX is regulated, how it functions within the coagulation cascade, and how structural changes affect its function. In this review, we will summarize current knowledge on the biology of factor IX, with a focus on its structure-function relationships, gene structure, and regulation.

摘要

凝血因子IX通过生成因子Xa在凝血的内源性途径中发挥关键作用,最终导致凝血酶形成。在过去50年里,广泛的研究加深了我们对因子IX的生物学、生理学、病理学、生物化学和分子遗传学的理解。这些丰富的知识揭示了因子IX基因和蛋白质是如何进化的,因子IX是如何被调控的,它在凝血级联反应中是如何发挥作用的,以及结构变化如何影响其功能。在这篇综述中,我们将总结关于因子IX生物学的当前知识,重点关注其结构-功能关系、基因结构和调控。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e904/12097292/7599b39f41c4/IUB-77-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e904/12097292/eeda7089438e/IUB-77-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e904/12097292/d4132b9f72e2/IUB-77-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e904/12097292/7599b39f41c4/IUB-77-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e904/12097292/eeda7089438e/IUB-77-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e904/12097292/d4132b9f72e2/IUB-77-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e904/12097292/7599b39f41c4/IUB-77-0-g002.jpg

相似文献

1
Blood Coagulation Factor IX: Structure, Function, and Regulation.血液凝固因子IX:结构、功能与调节
IUBMB Life. 2025 May;77(5):e70024. doi: 10.1002/iub.70024.
2
Blood coagulation factor IX: structural insights impacting hemophilia B therapy.凝血因子 IX:影响乙型血友病治疗的结构见解。
Blood. 2024 Nov 21;144(21):2198-2210. doi: 10.1182/blood.2023023276.
3
Factor V Deficiency因子V缺乏症
4
Self-management of oral anticoagulation therapy--methodological and clinical aspects.口服抗凝治疗的自我管理——方法学与临床方面
Dan Med Bull. 2011 May;58(5):B4284.
5
Hemophilia B乙型血友病
6
The Lived Experience of Autistic Adults in Employment: A Systematic Search and Synthesis.成年自闭症患者的就业生活经历:系统检索与综述
Autism Adulthood. 2024 Dec 2;6(4):495-509. doi: 10.1089/aut.2022.0114. eCollection 2024 Dec.
7
Understanding Glycogen Storage Disease Type IX: A Systematic Review with Clinical Focus-Why It Is Not Benign and Requires Vigilance.了解IX型糖原贮积病:一项以临床为重点的系统评价——为何它并非良性且需要警惕。
Genes (Basel). 2025 May 15;16(5):584. doi: 10.3390/genes16050584.
8
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
9
Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B.腺相关病毒基因疗法对重度乙型血友病的持续临床益处
N Engl J Med. 2025 Jun 12;392(22):2226-2234. doi: 10.1056/NEJMoa2414783.
10
Factor XI and XII inhibitors-Dawn of a new era.凝血因子XI和XII抑制剂——新时代的曙光。
Indian Heart J. 2025 Mar-Apr;77(2):122-129. doi: 10.1016/j.ihj.2025.02.007. Epub 2025 Feb 25.

本文引用的文献

1
Adeno-associated virus-based gene therapy for hemophilia-addressing the gaps.基于腺相关病毒的血友病基因治疗——填补空白
Res Pract Thromb Haemost. 2024 Dec 31;9(1):102673. doi: 10.1016/j.rpth.2024.102673. eCollection 2025 Jan.
2
An RNA aptamer exploits exosite-dependent allostery to achieve specific inhibition of coagulation factor IXa.一种 RNA 适体利用变构依赖的外位点来实现对凝血因子 IXa 的特异性抑制。
Proc Natl Acad Sci U S A. 2024 Jul 16;121(29):e2401136121. doi: 10.1073/pnas.2401136121. Epub 2024 Jul 10.
3
Extravascular factor IX pool fed by prophylaxis is a true hemostatic barrier against bleeding.
预防性输注所补充的血管外凝血因子IX储备是预防出血的真正止血屏障。
J Thromb Haemost. 2024 Mar;22(3):700-708. doi: 10.1016/j.jtha.2023.11.023. Epub 2023 Dec 9.
4
Factor IXa variants resistant to plasma inhibitors enhance clot formation in vivo.因子 IXa 变异体对血浆抑制剂的耐药性增强了体内血栓的形成。
Blood. 2023 Apr 20;141(16):2022-2032. doi: 10.1182/blood.2022018083.
5
SAXS analysis of the intrinsic tenase complex bound to a lipid nanodisc highlights intermolecular contacts between factors VIIIa/IXa.对结合到脂质纳米盘上的内源性凝血酶原酶复合物进行小角X射线散射分析,突出了凝血因子VIIIa/IXa之间的分子间接触。
Blood Adv. 2022 Jun 14;6(11):3240-3254. doi: 10.1182/bloodadvances.2021005874.
6
F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes.F9 错义突变会损害因子 IX 的激活,与多种血浆表型相关。
J Thromb Haemost. 2022 Jan;20(1):69-81. doi: 10.1111/jth.15552. Epub 2021 Oct 24.
7
Hyperactivity of factor IX Padua (R338L) depends on factor VIIIa cofactor activity.因子 IX Padua(R338L)的过度活跃依赖于因子 VIIIa 辅因子活性。
JCI Insight. 2019 Jun 20;5(14):128683. doi: 10.1172/jci.insight.128683.
8
Anticoagulant Protein S Targets the Factor IXa Heparin-Binding Exosite to Prevent Thrombosis.抗凝蛋白 S 靶向因子 IXa 肝素结合外显子以预防血栓形成。
Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):816-828. doi: 10.1161/ATVBAHA.117.310588. Epub 2018 Feb 1.
9
Hepatocyte Is a Sole Cell Type Responsible for the Production of Coagulation Factor IX In Vivo.肝细胞是体内负责产生凝血因子IX的唯一细胞类型。
Cell Med. 2012 May 14;3(1-3):25-31. doi: 10.3727/215517912X639496. eCollection 2012 Jan.
10
Extravascular FIX and coagulation.血管外凝血因子IX与凝血
Thromb J. 2016 Oct 4;14(Suppl 1):35. doi: 10.1186/s12959-016-0104-2. eCollection 2016.